Status:
COMPLETED
A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV Infections
Hepatitis C
Eligibility:
All Genders
13+ years
Brief Summary
This study evaluates patients infected with both HIV and Hepatitis C virus (HCV) who are receiving anti-HIV drugs. The purpose of this study is to learn more about HCV infection in patients whose HIV ...
Detailed Description
Sixty naive patients with HIV and confirmed hepatitis C who are co-enrolled in another AACTG antiretroviral study that involves the testing of HAART (Highly Active Antiretroviral Therapy) are entered ...
Eligibility Criteria
Inclusion Criteria
Patients may be eligible for this study if they:
- Are HIV-positive and have Hepatitis C.
- Have an HIV blood level of at least 2,500 copies/ml 30 days before study entry.
- Are co-enrolled in an active adult AIDS clinical trial using anti-HIV treatment.
- Are at least 13 years of age (parent or guardian consent required if under 18).
Exclusion Criteria
Patients will not be eligible for this study if they:
- Have liver disease.
- Have cancer requiring chemotherapy.
- Have Hepatitis B.
- Abuse alcohol and/or drugs.
- Have received certain antiretroviral (anti-HIV) drugs in the past.
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00001117
Last Update
August 1 2008
Active Locations (43)
Enter a location and click search to find clinical trials sorted by distance.
1
Univ of Southern California / LA County USC Med Ctr
Los Angeles, California, United States, 900331079
2
Willow Clinic
Menlo Park, California, United States, 94025
3
Univ of California / San Diego Treatment Ctr
San Diego, California, United States, 921036325
4
San Francisco Gen Hosp
San Francisco, California, United States, 941102859